We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+23.32%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.14B
AUM Growth
-$11.8M
Cap. Flow
+$77.2M
Cap. Flow %
6.76%
Top 10 Hldgs %
64.3%
Holding
85
New
15
Increased
23
Reduced
19
Closed
17

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$51.9M
2
CTLT
CATALENT, INC.
CTLT
+$37.6M
3
SNY icon
Sanofi
SNY
+$26.7M
4
BIIB icon
Biogen
BIIB
+$21.8M
5
GSK icon
GSK
GSK
+$18.4M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$96.3M
2
CYH icon
Community Health Systems
CYH
+$21M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$17M
4
LNTH icon
Lantheus
LNTH
+$14.6M
5
ABMD
Abiomed Inc
ABMD
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 89.7%
2 Miscellaneous 9.48%
3 Communication Services 0.77%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGEN icon
26
Repligen
RGEN
$9.95B
$9.65M 0.85%
57,004
+53,363
+1,466% +$9.68M
IONS icon
27
Ionis Pharmaceuticals
IONS
$10.1B
$9.1M 0.8%
240,975
+39,142
+19% +$1.65M
MODN
28
DELISTED
MODEL N, INC.
MODN
$8.84M 0.77%
+217,880
New +$8.2M
CYH icon
29
Community Health Systems
CYH
$413M
$8.65M 0.76%
2,001,994
-6,839,610
-77% -$21M
PCVX icon
30
Vaxcyte
PCVX
$8.9B
$8.56M 0.75%
+178,453
New +$7M
LQDA icon
31
Liquidia Corp
LQDA
$6.06B
$8.22M 0.72%
1,290,913
-110,530
-8% -$594K
APLS
32
DELISTED
Apellis Pharmaceuticals
APLS
$8M 0.7%
+154,796
New +$8.21M
VERA icon
33
Vera Therapeutics
VERA
$2.46B
$7.96M 0.7%
411,308
+255,179
+163% +$4.62M
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.51M 0.66%
+350,747
New +$7.49M
XBI icon
35
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$7.47M 0.65%
90,000
– –
TARO
36
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$6.55M 0.57%
225,462
+2,079
+0.9% +$61.7K
PBYI icon
37
Puma Biotechnology
PBYI
$468M
$6.38M 0.56%
1,507,663
+1,958
+0.1% +$6.76K
MRK icon
38
CALL
Merck
MRK
$366B
$5.4M 0.47%
48,700
– –
EOLS icon
39
Evolus
EOLS
$587M
$5.36M 0.47%
+713,774
New +$5.53M
INCY icon
40
Incyte
INCY
$25.2B
$5.14M 0.45%
+63,996
New +$4.9M
GH icon
41
Guardant Health
GH
$21.7B
$3.97M 0.35%
146,129
-25,352
-15% -$1.16M
AMRN
42
Amarin Corp
AMRN
$295M
$3.97M 0.35%
164,206
-433,931
-73% -$10.4M
MRUS
43
DELISTED
Merus
MRUS
$2.86M 0.25%
184,556
-92,117
-33% -$1.62M
JBIO
44
Jade Biosciences
JBIO
$1.33B
$2.67M 0.23%
+2,607
New +$1.89M
PLRX icon
45
Pliant Therapeutics
PLRX
$68.7M
$2.66M 0.23%
137,423
-156,680
-53% -$3.28M
CABA icon
46
Cabaletta Bio
CABA
$529M
$2.62M 0.23%
282,874
-277,592
-50% -$1.01M
BHVN icon
47
Biohaven
BHVN
$2.33B
$2.58M 0.23%
+185,595
New +$2.62M
TEVA icon
48
CALL
Teva Pharmaceuticals
TEVA
$42.5B
$2.49M 0.22%
272,900
– –
IQV icon
49
IQVIA
IQV
$43.1B
$2.23M 0.2%
10,889
+2,592
+31% +$526K
A icon
50
Agilent Technologies
A
$43.4B
$1.78M 0.16%
11,878
-9,643
-45% -$1.38M
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Eversept Partners held 85 positions worth $1.14B, down 1% from $1.15B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Eversept Partners deployed $77.2M of net new capital in Q4 2022, opening 15 new positions and adding to 23 existing holdings. Its largest new stake was CATALENT, INC.: 691,677 shares worth $31.1M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 72% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Community Health Systems, an estimated $21M trimmed.

  • Eversept Partners's largest Q4 2022 buy was CATALENT, INC.: 691,677 shares worth $31.1M.
  • Eversept Partners added most to Natera in Q4 2022, an estimated $51.9M increase.
  • Eversept Partners's biggest Q4 2022 reduction was Community Health Systems, cutting an estimated $21M.
  • Eversept Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $96.3M.
  • Eversept Partners's ten largest holdings make up 64% of its $1.14B portfolio in Q4 2022.
  • Eversept Partners opened 15 new positions and closed 17 in Q4 2022.
  • Eversept Partners's portfolio value fell 1% quarter-over-quarter to $1.14B.

Based on Eversept Partners's 13F filing for Q4 2022, filed 14 Feb 2023.